Acute Ischemic Stroke, AV Fistula, AVM - Cerebral Arteriovenous Malformation, Extracranial Atherosclerosis, Intracranial Aneurysm
Conditions
Brief summary
This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.
Interventions
DEVICETarvos Microguidewire
This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.
Sponsors
Keuro MedTech
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Undertaken a neurovascular surgery procedure including Tarvos microguidewire * Available images of Tarvos Microguidewire in the neurovascular surgery.
Exclusion criteria
* Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome) * Prior vascular dissection or injury to the target vessels * Not meeting the data requirements needed for this study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Device success rate | during surgery | Number of patients with device success / Number of recruited patients\* 100% |
Secondary
| Measure | Time frame |
|---|---|
| Ability to assist in the delivery of other interventional devices to the targeted vessel position. | during surgery |
Countries
China
Outcome results
None listed